No black box warning on record for Fosinopril Sodium And Hydrochlorothiazide

As of the latest FDA labeling reviewed, Fosinopril Sodium And Hydrochlorothiazide (FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Fosinopril Sodium And Hydrochlorothiazide medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including fosinopril sodium and hydrochlorothiazide) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema Angioedema of

No black box warning on record for Fosinopril Sodium And Hydrochlorothiazide

Other warnings & precautions

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including fosinopril sodium and hydrochlorothiazide) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema Angioedema of

Fosinopril Sodium And Hydrochlorothiazide Black Box Warning

No black box warning on record for Fosinopril Sodium And Hydrochlorothiazide

Other warnings & precautions

Fosinopril Sodium And Hydrochlorothiazide Black Box Warning

No black box warning on record for Fosinopril Sodium And Hydrochlorothiazide

Other warnings & precautions